0
     

Report Added
Report already added
Global Minimally Invasive Biopsy Techniques Market By Product Offered (Tests, Kits & Consumables, Instruments), By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others {Breath Biopsy etc.}), By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others {miRNA, CTECs, circRNA etc.}), By Application (Clinical v/s Therapeutic), By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions), By Region, Competition Forecast & Opportunities, 2027

Global Minimally Invasive Biopsy Techniques Market By Product Offered (Tests, Kits & Consumables, Instruments), By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others {Breath Biopsy etc.}), By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others {miRNA, CTECs, circRNA etc.}), By Application (Clinical v/s Therapeutic), By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions), By Region, Competition Forecast & Opportunities, 2027

Global Minimally Invasive Biopsy Techniques Market stood at USD 4,501.20 million in 2021 and is expected to grow at a CAGR of 12.36% during the forecast period. When compared to open diagnostic surgery, minimally invasive biopsy reduces the number of surgical treatments required. In individuals with suspected or ambiguous breast lesions which can be identified by imaging, minimally invasive biopsy has taken the place of open excisional biopsy. When compared to surgical excision, Minimally Invasive Biopsy (MIB) has a similar or higher level of precision which lessens the psychological toll on the patients and is less economical. Compared to open diagnostic surgery, MIB reduces the number of surgical procedures needed in patients with impalpable cancers like breast cancer. The increased need for biopsy testing to detect cancerous cells, identify autoimmune, inflammatory, and infectious diseases, as well as the wide adoption of less invasive surgical methods has increased in the past few years and has highlighted the need for its further expansion. Early cancer detection and increased precision compared to incisional and excisional biopsies have been the constant drivers of this sector. The biopsy with minimally invasiveness can detect cancer and advance the treatment monitoring and selection. The minimal invasive biopsy can be performed more than one time in comparison to the surgical biopsy for tissue extraction providing more ease in the biopsy process and detection of different type of cancers.
Rise in Cancer Cases Due to Multiple Factors
In many nations with low and medium Human Development Index (HDI), significant lifestyle changes, sociocultural contexts, and environments significantly impact the incidence of risk factors for cancers. The delaying of childbearing and having fewer children, as well as higher levels of excess body weight and physical inactivity, are among the common risk factors which increase the chances of breast cancer. Breast cancer incidence rates are increasing globally. Due to lifestyle variables, including smoking, obesity, and alcohol consumption, cancer tends to be more common in high-income countries. It also predominates in nations with good health care systems, which can identify and cure cancer more effectively than those in low-income countries. Furthermore, cancer survival rates in every nation continue to rise because of developments in medical knowledge and technology. Even while a smaller percentage of cancer patients pass away from the illness, the overall number of cancer-related deaths is rising. This is sometimes ascribed to the fact that the world's population is aging faster than ever before, which increases the risk of developing cancer. The most common ways to express cancer rates are as a crude rate or an age-standardized rate, which accounts for the fact that some nations' populations are often younger than others. Thus, early diagnosis and prevention is the basic step to decreasing the mortality rates, which is now being focused on the implementation of more awareness for the use of minimally invasive techniques for conducting biopsies.
Integration of Artificial Intelligence Will Support the Market Growth
The growing use of robotics in biopsy operations is one of the key trends in the market for minimally invasive biopsy technology. Robotic surgery has increased surgical accuracy and better vision of the operating site. Due to its capacity to offer greater control, and range of motion compared to conventional open operations, these devices are now being used more frequently.
Another development is the use of molecular imaging powered by Artificial Intelligence, which has the potential to significantly improve the diagnosis of colorectal cancer. AI algorithms enable the comparison of a patient's current information with vast databases of patients who have already received treatment, potentially enabling the choice of the best treatment option and the prediction of the outcome of that option. In the case of colorectal cancers, capsule endoscopy (CE), which is a minimally invasive diagnostic method, is a potent alternate strategy. Traditionally, colon CE has been a labor-intensive process that relies on human interpretation and analysis of the photographed pictures to find probable colorectal cancer (CRC) lesions. As the small intestine cannot be reached by traditional upper endoscopy or by colonoscopy, the use of capsule endoscopy provides an accessible way to evaluate the small intestine by the doctor.
Another AI advancement can be seen in liquid biopsies, where due to the size and complexity of the data produced by liquid biopsies, existing approaches are unable to process them efficiently. For automated assessments of these data and future predictions, machine learning is a potential method. Numerous ML techniques, including SVM, random forest (RF), and ANNs, have been successfully applied in the medical industry.
Initiatives at Global Level to Support Market Growth
WHO and IARC have collaborated with other UN organizations to enhance political commitment to cancer prevention and control globally. It aims to carry out research on the causes of human cancer and the mechanisms of carcinogenesis; and interact with other UN entities, including the International Atomic Energy Agency to track the prevalence of cancer (as part of the Global Initiative on Cancer Registries’ activities) to reach out the countries where the availability of data is limited.
It is also focusing to determine the "best buys" and other high-priority, cost-effective cancer preventive and control measures which includes minimally invasive biopsy techniques and is also providing guidelines and standards to direct the development and application of programs for cancer prevention, early detection, screening, treatment, palliative care, and survivorship care in both adults and children.
The initiative also includes creating awareness for the application of minimally invasive biopsy techniques to enhance access to cancer treatments by bolstering local and national health systems.
Increasing Proliferation of the Minimally Invasive Surgical Procedure
Core needle biopsy and fine needle aspiration biopsy are two minimally invasive biopsy methods which are extensively used in breast biopsy and have several advantages over surgical biopsy. The costs are lower, there is less scarring, the diagnostic accuracy is almost the same, and there is no need for general anesthesia or sedation with minimally invasive biopsy. In nations with low resources, where patients frequently arrive with advanced-stage breast cancer, a minimally invasive biopsy can enable accurate diagnosis and quick care in a cost-effective manner. The execution of a successful program in minimally invasive breast biopsy is marked by several events: public awareness of these procedures' for being less invasive in nature, which can encourage women to seek care early; a shift in medical professionals' treatment philosophies that favors patient involvement in decision-making and acceptance of less intrusive but reliable diagnostic techniques.
Market Segmentation
The Global Minimally Invasive Biopsy Techniques market is segmented based on Product Offered, Technique, Circulating Biomarker, Application, End User, region and company. Based on Product Offered, the market can be split into Tests, Kits & Consumables, Instruments. Based on Technique, the market is segmented into Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others. Based on the Circulating Biomarker, the segment is divided into Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Extracellular Vesicles, Others. Based on Application, the market is bifurcated into Clinical and Therapeutic application. The Clinical application is sub segmented into Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others. Similarly, the Therapeutic Application is further sub segmented into Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others. Based on the End User, the market is divided Hospitals & Clinics, Academic & Research Institutions and Ambulatory Care Centers.
Company Profiles
Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, QIAGEN NV, Guardant Health, Inc., Veracyte, Inc., Myriad Genetics, Inc., Biocept, Inc., NeoGenomics Laboratories, Inc., Adaptive Biotechnologies Corporation, DermTech, Inc. are among the major market players operating in the Global Minimally Invasive Biopsy Techniques market.

Report Scope:
In this report, Global Minimally Invasive Biopsy Techniques market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Minimally Invasive Biopsy Techniques Market, By Product Offered:
oTests
oKits & Consumables
oInstruments
•Minimally Invasive Biopsy Techniques Market, By Technique:
oLiquid Biopsy
oOptical Biopsy
oBrush Biopsy
oPigmented Lesion Assays
oOthers (Breath Biopsy etc.)
•Minimally Invasive Biopsy Techniques Market, By Circulating Biomarker:
oCirculating Tumor Cells (CTCs)
oCell Free DNA (cfDNA)
oCirculating Tumor DNA (ctDNA)
oExtracellular Vesicles
oOthers (miRNA, CTECs, circRNA etc.)
•Minimally Invasive Biopsy Techniques Market, By Application:
oClinical
oTherapeutic
•Minimally Invasive Biopsy Techniques Market, By Clinical Application
oTreatment Monitoring
oPrognosis & Recurrence Monitoring
oTreatment Selection
o Others (Diagnosis and Screening etc.)
•Minimally Invasive Biopsy Techniques Market, By Therapeutic Application
oBreast Cancer
oLung Cancer
oProstate Cancer
oColorectal Cancer
oOthers (Blood Cancer, Thyroid Cancer etc.)
•Minimally Invasive Biopsy Techniques Market, By End User:
oHospitals & Clinics
oAmbulatory Care Centers
oAcademic & Research Institutions
•Minimally Invasive Biopsy Techniques Market, By Region:
oNorth America
•United States
•Canada
•Mexico
o Europe
•Germany
•France
•United Kingdom
•Italy
•Spain
•Poland
oAsia-Pacific
•China
•India
•Japan
•South Korea
•Australia
•Thailand
•Vietnam
•Malaysia

oSouth America
•Brazil
•Argentina
•Colombia
oMiddle East & Africa
•Turkey
•Egypt
•South Africa
•Saudi Arabia
•UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Minimally Invasive Biopsy Techniques market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).
Table of Contents

1.Service Overview
2.Research Methodology
3.Executive Summary
4.Impact of COVID-19 on Global Minimally Invasive Biopsy Techniques Market
5.Voice of Customer
6.Clinical Trial Analysis
7.Patent Analysis
8.Global Minimally Invasive Biopsy Techniques Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Product Offered (Tests, Kits & Consumables, Instruments)
8.2.2.By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others {Breath Biopsy etc.})
8.2.3.By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others {miRNA, CTECs, circRNA etc.})
8.2.4.By Application (Clinical v/s Therapeutic)
8.2.4.1.By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
8.2.4.2.By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
8.2.5.By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Centers)
8.2.6.By Company (2021)
8.2.7.By Region
8.3.Market Map
9.North America Minimally Invasive Biopsy Techniques Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Product Offered (Tests, Kits & Consumables, Instruments)
9.2.2.By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, {Breath Biopsy etc.})
9.2.3.By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, {miRNA, CTECs, circRNA etc.})
9.2.4.By Application (Clinical v/s Therapeutic)
9.2.4.1.By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
9.2.4.2.By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
9.2.5.By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Centers)
9.2.6.By Country
9.3.North America: Country Analysis
9.3.1.United States Minimally Invasive Biopsy Techniques Market Outlook
9.3.1.1.Market Size & Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share & Forecast
9.3.1.2.1.By Product Offered
9.3.1.2.2.By Technique
9.3.1.2.3.By Circulating Biomarker
9.3.1.2.4.By Application
9.3.1.2.5.By End User
9.3.2.Canada Minimally Invasive Biopsy Techniques Market Outlook
9.3.2.1.Market Size & Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share & Forecast
9.3.2.2.1.By Product Offered
9.3.2.2.2.By Technique
9.3.2.2.3.By Circulating Biomarker
9.3.2.2.4.By Application
9.3.2.2.5.By End User
9.3.3.Mexico Minimally Invasive Biopsy Techniques Market Outlook
9.3.3.1.Market Size & Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share & Forecast
9.3.3.2.1.By Product Offered
9.3.3.2.2.By Technique
9.3.3.2.3.By Circulating Biomarker
9.3.3.2.4.By Application
9.3.3.2.5.By End User
10.Europe Minimally Invasive Biopsy Techniques Market Outlook
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.By Product Offered (Tests, Kits & Consumables, Instruments)
10.2.2.By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, {Breath Biopsy etc.})
10.2.3.By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, {miRNA, CTECs, circRNA etc.})
10.2.4.By Application (Clinical v/s Therapeutic)
10.2.4.1.By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
10.2.4.2.By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
10.2.5.By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Center)
10.2.6.By Country
10.3.Europe: Country Analysis
10.3.1.Germany Minimally Invasive Biopsy Techniques Market Outlook
10.3.1.1.Market Size & Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share & Forecast
10.3.1.2.1.By Product Offered
10.3.1.2.2.By Technique
10.3.1.2.3.By Circulating Biomarker
10.3.1.2.4.By Application
10.3.1.2.5.By End User
10.3.2.France Minimally Invasive Biopsy Techniques Market Outlook
10.3.2.1.Market Size & Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share & Forecast
10.3.2.2.1.By Product Offered
10.3.2.2.2.By Technique
10.3.2.2.3.By Circulating Biomarker
10.3.2.2.4.By Application
10.3.2.2.5.By End User
10.3.3.United Kingdom Minimally Invasive Biopsy Techniques Market Outlook
10.3.3.1.Market Size & Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share & Forecast
10.3.3.2.1.By Product Offered
10.3.3.2.2.By Technique
10.3.3.2.3.By Circulating Biomarker
10.3.3.2.4.By Application
10.3.3.2.5.By End User
10.3.4.Italy Minimally Invasive Biopsy Techniques Market Outlook
10.3.4.1.Market Size & Forecast
10.3.4.1.1.By Value
10.3.4.2.Market Share & Forecast
10.3.4.2.1.By Product Offered
10.3.4.2.2.By Technique
10.3.4.2.3.By Circulating Biomarker
10.3.4.2.4.By Application
10.3.4.2.5.By End User
10.3.5.Spain Minimally Invasive Biopsy Techniques Market Outlook
10.3.5.1.Market Size & Forecast
10.3.5.1.1.By Value
10.3.5.2.Market Share & Forecast
10.3.5.2.1.By Product Offered
10.3.5.2.2.By Technique
10.3.5.2.3.By Circulating Biomarker
10.3.5.2.4.By Application
10.3.5.2.5.By End User
10.3.6.Poland Minimally Invasive Biopsy Techniques Market Outlook
10.3.6.1.Market Size & Forecast
10.3.6.1.1.By Value
10.3.6.2.Market Share & Forecast
10.3.6.2.1.By Product Offered
10.3.6.2.2.By Technique
10.3.6.2.3.By Circulating Biomarker
10.3.6.2.4.By Application
10.3.6.2.5.By End User
11.Asia-Pacific Minimally Invasive Biopsy Techniques Market Outlook
11.1.Market Size & Forecast
11.1.1.By Value
11.2.Market Share & Forecast
11.2.1.By Product Offered (Tests, Kits & Consumables, Instruments)
11.2.2.By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, {Breath Biopsy etc.})
11.2.3.By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, {miRNA, CTECs, circRNA etc.})
11.2.4.By Application (Clinical v/s Therapeutic)
11.2.4.1.By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
11.2.4.2.By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
11.2.5.By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Center)
11.2.6.By Country
11.3.Asia-Pacific: Country Analysis
11.3.1.China Minimally Invasive Biopsy Techniques Market Outlook
11.3.1.1.Market Size & Forecast
11.3.1.1.1.By Value
11.3.1.2.Market Share & Forecast
11.3.1.2.1.By Product Offered
11.3.1.2.2.By Technique
11.3.1.2.3.By Circulating Biomarker
11.3.1.2.4.By Application
11.3.1.2.5.By End User
11.3.2.India Minimally Invasive Biopsy Techniques Market Outlook
11.3.2.1.Market Size & Forecast
11.3.2.1.1.By Value
11.3.2.2.Market Share & Forecast
11.3.2.2.1.By Product Offered
11.3.2.2.2.By Technique
11.3.2.2.3.By Circulating Biomarker
11.3.2.2.4.By Application
11.3.2.2.5.By End User
11.3.3.Japan Minimally Invasive Biopsy Techniques Market Outlook
11.3.3.1.Market Size & Forecast
11.3.3.1.1.By Value
11.3.3.2.Market Share & Forecast
11.3.3.2.1.By Product Offered
11.3.3.2.2.By Technique
11.3.3.2.3.By Circulating Biomarker
11.3.3.2.4.By Application
11.3.3.2.5.By End User
11.3.4.South Korea Minimally Invasive Biopsy Techniques Market Outlook
11.3.4.1.Market Size & Forecast
11.3.4.1.1.By Value
11.3.4.2.Market Share & Forecast
11.3.4.2.1.By Product Offered
11.3.4.2.2.By Technique
11.3.4.2.3.By Circulating Biomarker
11.3.4.2.4.By Application
11.3.4.2.5.By End User
11.3.5.Australia Minimally Invasive Biopsy Techniques Market Outlook
11.3.5.1.Market Size & Forecast
11.3.5.1.1.By Value
11.3.5.2.Market Share & Forecast
11.3.5.2.1.By Product Offered
11.3.5.2.2.By Technique
11.3.5.2.3.By Circulating Biomarker
11.3.5.2.4.By Application
11.3.5.2.5.By End User
11.3.6.Thailand Minimally Invasive Biopsy Techniques Market Outlook
11.3.6.1.Market Size & Forecast
11.3.6.1.1.By Value
11.3.6.2.Market Share & Forecast
11.3.6.2.1.By Product Offered
11.3.6.2.2.By Technique
11.3.6.2.3.By Circulating Biomarker
11.3.6.2.4.By Application
11.3.6.2.5.By End User
11.3.7.Vietnam Minimally Invasive Biopsy Techniques Market Outlook
11.3.7.1.Market Size & Forecast
11.3.7.1.1.By Value
11.3.7.2.Market Share & Forecast
11.3.7.2.1.By Product Offered
11.3.7.2.2.By Technique
11.3.7.2.3.By Circulating Biomarker
11.3.7.2.4.By Application
11.3.7.2.5.By End User
11.3.8.Malaysia Minimally Invasive Biopsy Techniques Market Outlook
11.3.8.1.Market Size & Forecast
11.3.8.1.1.By Value
11.3.8.2.Market Share & Forecast
11.3.8.2.1.By Product Offered
11.3.8.2.2.By Technique
11.3.8.2.3.By Circulating Biomarker
11.3.8.2.4.By Application
11.3.8.2.5.By End User
12.South America Minimally Invasive Biopsy Techniques Market Outlook
12.1.Market Size & Forecast
12.1.1.By Value
12.2.Market Share & Forecast
12.2.1.By Product Offered (Tests, Kits & Consumables, Instruments)
12.2.2.By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, {Breath Biopsy etc.})
12.2.3.By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, {miRNA, CTECs, circRNA etc.})
12.2.4.By Application (Clinical v/s Therapeutic)
12.2.4.1.By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
12.2.4.2.By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
12.2.5.By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Center)
12.2.6.By Country
12.3.South America: Country Analysis
12.3.1.Brazil Minimally Invasive Biopsy Techniques Market Outlook
12.3.1.1.Market Size & Forecast
12.3.1.1.1.By Value
12.3.1.2.Market Share & Forecast
12.3.1.2.1.By Product Offered
12.3.1.2.2.By Technique
12.3.1.2.3.By Circulating Biomarker
12.3.1.2.4.By Application
12.3.1.2.5.By End User
12.3.2.Argentina Minimally Invasive Biopsy Techniques Market Outlook
12.3.2.1.Market Size & Forecast
12.3.2.1.1.By Value
12.3.2.2.Market Share & Forecast
12.3.2.2.1.By Product Offered
12.3.2.2.2.By Technique
12.3.2.2.3.By Circulating Biomarker
12.3.2.2.4.By Application
12.3.2.2.5.By End User
12.3.3.Colombia Minimally Invasive Biopsy Techniques Market Outlook
12.3.3.1.Market Size & Forecast
12.3.3.1.1.By Value
12.3.3.2.Market Share & Forecast
12.3.3.2.1.By Product Offered
12.3.3.2.2.By Technique
12.3.3.2.3.By Circulating Biomarker
12.3.3.2.4.By Application
12.3.3.2.5.By End User
13.Middle East and Africa Minimally Invasive Biopsy Techniques Market Outlook
13.1.Market Size & Forecast
13.1.1.By Value
13.2.Market Share & Forecast
13.2.1.By Product Offered (Tests, Kits & Consumables, Instruments)
13.2.2.By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, {Breath Biopsy etc.})
13.2.3.By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, {miRNA, CTECs, circRNA etc.})
13.2.4.By Application (Clinical v/s Therapeutic)
13.2.4.1.By Clinical Application (Treatment Monitoring, Prognosis & Recurrence Monitoring, Treatment Selection, Others {Diagnosis and Screening etc.})
13.2.4.2.By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Others {Blood Cancer, Thyroid Cancer etc.})
13.2.5.By End User (Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Center)
13.2.6.By Country
13.3.MEA: Country Analysis
13.3.1.Turkey Minimally Invasive Biopsy Techniques Market Outlook
13.3.1.1.Market Size & Forecast
13.3.1.1.1.By Value
13.3.1.2.Market Share & Forecast
13.3.1.2.1.By Product Offered
13.3.1.2.2.By Technique
13.3.1.2.3.By Circulating Biomarker
13.3.1.2.4.By Application
13.3.1.2.5.By End User
13.3.2.Egypt Minimally Invasive Biopsy Techniques Market Outlook
13.3.2.1.Market Size & Forecast
13.3.2.1.1.By Value
13.3.2.2.Market Share & Forecast
13.3.2.2.1.By Product Offered
13.3.2.2.2.By Technique
13.3.2.2.3.By Circulating Biomarker
13.3.2.2.4.By Application
13.3.2.2.5.By End User
13.3.3.South Africa Minimally Invasive Biopsy Techniques Market Outlook
13.3.3.1.Market Size & Forecast
13.3.3.1.1.By Value
13.3.3.2.Market Share & Forecast
13.3.3.2.1.By Product Offered
13.3.3.2.2.By Technique
13.3.3.2.3.By Circulating Biomarker
13.3.3.2.4.By Application
13.3.3.2.5.By End User
13.3.4.Saudi Arabia Minimally Invasive Biopsy Techniques Market Outlook
13.3.4.1.Market Size & Forecast
13.3.4.1.1.By Value
13.3.4.2.Market Share & Forecast
13.3.4.2.1.By Product Offered
13.3.4.2.2.By Technique
13.3.4.2.3.By Circulating Biomarker
13.3.4.2.4.By Application
13.3.4.2.5.By End User
13.3.5.UAE Minimally Invasive Biopsy Techniques Market Outlook
13.3.5.1.Market Size & Forecast
13.3.5.1.1.By Value
13.3.5.2.Market Share & Forecast
13.3.5.2.1.By Product Offered
13.3.5.2.2.By Technique
13.3.5.2.3.By Circulating Biomarker
13.3.5.2.4.By Application
13.3.5.2.5.By End User
14.Market Dynamics
14.1.Drivers
14.2.Challenges
15.Market Trends & Developments
16.Competitive Landscape (Inclusive of SWOT Analysis)
16.1.Thermo Fisher Scientific, Inc.
16.2.F. Hoffmann-La Roche AG
16.3.QIAGEN NV
16.4.Guardant Health, Inc.
16.5.Veracyte, Inc.
16.6.Myriad Genetics, Inc.
16.7.Biocept, Inc.
16.8.NeoGenomics Laboratories, Inc.
16.9.Adaptive Biotechnologies Corporation
16.10.DermTech, Inc.
17.Strategic Recommendations
18.About Us & Disclaimer

List of Figure
Figure 1: Global Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 3: Global Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 4: Global Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 5: Global Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 6: Global Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 7: Global Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 8: Global Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 9: Global Minimally Invasive Biopsy Techniques Market Share, By Region, By Value, 2017-2027F
Figure 10: Global Minimally Invasive Biopsy Techniques Market Share, By Company, By Value, 2021
Figure 11: Global Minimally Invasive Biopsy Techniques Market Map, By Product Offered, Market Size (USD Million) & Growth Rate (%), 2021
Figure 12: Global Minimally Invasive Biopsy Techniques Market Map, By Technique, Market Size (USD Million) & Growth Rate (%), 2021
Figure 13: Global Minimally Invasive Biopsy Techniques Market Map, By Circulating Biomarker Market Size (USD Million) & Growth Rate (%), 2021
Figure 14: Global Minimally Invasive Biopsy Techniques Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2021
Figure 15: Global Minimally Invasive Biopsy Techniques Market Map, By Clinical Application, Market Size (USD Million) & Growth Rate (%), 2021
Figure 16: Global Minimally Invasive Biopsy Techniques Market Map, By Therapeutic Application, Market Size (USD Million) & Growth Rate (%), 2021
Figure 17: Global Minimally Invasive Biopsy Techniques Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2021

Figure 18: Global Minimally Invasive Biopsy Techniques Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021

Figure 19: North America Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 20: North America Minimally Invasive Biopsy Techniques Market Share, By Product, By Value, 2017-2027F
Figure 21: North America Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 22: North America Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 23: North America Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 24: North America Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 25: North America Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 26: North America Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 27: North America Minimally Invasive Biopsy Techniques Market Share, By Country, By Value, 2017-2027F
Figure 28: United States Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 29: United States Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 30: United States Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 31: United States Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 32: United States Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F

Figure 33: United States Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F

Figure 34: Canada Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 35: Canada Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 36: Canada Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 37: Canada Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 38: Canada Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 39: Canada Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 40: Mexico Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 41: Mexico Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 42: Mexico Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 43: Mexico Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 44: Mexico Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 45: Mexico Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 46: Europe Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 47: Europe Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 48: Europe Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 49: Europe Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 50: Europe Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 51: Europe Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 52: Europe Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 53: Europe Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F

Figure 54: Europe Minimally Invasive Biopsy Techniques Market Share, By Country, By Value, 2017-2027F
Figure 55: Germany Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 56: Germany Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 57: Germany Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 58: Germany Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 59: Germany Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 60: Germany Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 61: France Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 62: France Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 63: France Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 64: France Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 65: France Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 66: France Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 67: United Kingdom Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 68: United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 69: United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 70: United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 71: United Kingdom Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 72: United Kingdom Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 73: Italy Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 74: Italy Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 75: Italy Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 76: Italy Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 77: Italy Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 78: Italy Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 79: Spain Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 80: Spain Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 81: Spain Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 82: Spain Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 83: Spain Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 84: Spain Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 85: Poland Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 86: Poland Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 87: Poland Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 88: Poland Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 89: Poland Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 90: Poland Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 91: Asia-Pacific Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 92: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 93: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 94: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 95: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 96: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 97: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 98: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F

Figure 99: Asia-Pacific Minimally Invasive Biopsy Techniques Market Share, By Country, By Value, 2017-2027F
Figure 100: China Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 101: China Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 102: China Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 103: China Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 104: China Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 105: China Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 106: India Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 107: India Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 108: India Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 109: India Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 110: India Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 111: India Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 112: Japan Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 113: Japan Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 114: Japan Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 115: Japan Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 116: Japan Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 117: Japan Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 118: South Korea Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 119: South Korea Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 120: South Korea Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 121: South Korea Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 122: South Korea Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 123: South Korea Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 124: Australia Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 125: Australia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 126: Australia Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 127: Australia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 128: Australia Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 129: Australia Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 130: Thailand Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 131: Thailand Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 132: Thailand Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 133: Thailand Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 134: Thailand Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 135: Thailand Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 136: Vietnam Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 137: Vietnam Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 138: Vietnam Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 139: Vietnam Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 140: Vietnam Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 141: Vietnam Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 142: Malaysia Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 143: Malaysia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 144: Malaysia Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 145: Malaysia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 146: Malaysia Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 147: Malaysia Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 148: South America Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 149: South America Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 150: South America Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 151: South America Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 152: South America Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 153: South America Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 154: South America Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 155: South America Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 156: South America Minimally Invasive Biopsy Techniques Market Share, By Country, By Value, 2017-2027F
Figure 157: Brazil Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 158: Brazil Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 159: Brazil Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 160: Brazil Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 161: Brazil Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 162: Brazil Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 163: Argentina Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 164: Argentina Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 165: Argentina Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 166: Argentina Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 167: Argentina Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 168: Argentina Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 169: Colombia Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 170: Colombia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 171: Colombia Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 172: Colombia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 173: Colombia Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 174: Colombia Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 175: Middle East and Africa Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 176: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 177: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 178: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 179: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 180: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Clinical Application, By Value, 2017-2027F
Figure 181: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Therapeutic Application, By Value, 2017-2027F
Figure 182: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 183: Middle East and Africa Minimally Invasive Biopsy Techniques Market Share, By Country, By Value, 2017-2027F
Figure 184: Turkey Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 185: Turkey Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 186: Turkey Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 187: Turkey Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 188: Turkey Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 189: Turkey Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 190: Egypt Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 191: Egypt Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 192: Egypt Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 193: Egypt Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 194: Egypt Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 195: Egypt Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 196: South Africa Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 197: South Africa Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 198: South Africa Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 199: South Africa Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 200: South Africa Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 201: South Africa Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 202: Saudi Arabia Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 203: Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 204: Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 205: Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 206: Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 207: Saudi Arabia Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F
Figure 208: UAE Minimally Invasive Biopsy Techniques Market Size, By Value (USD Million), 2017-2027F
Figure 209: UAE Minimally Invasive Biopsy Techniques Market Share, By Product Offered, By Value, 2017-2027F
Figure 210: UAE Minimally Invasive Biopsy Techniques Market Share, By Technique, By Value, 2017-2027F
Figure 211: UAE Minimally Invasive Biopsy Techniques Market Share, By Circulating Biomarker, By Value, 2017-2027F
Figure 212: UAE Minimally Invasive Biopsy Techniques Market Share, By Application, By Value, 2017-2027F
Figure 213: UAE Minimally Invasive Biopsy Techniques Market Share, By End User, By Value, 2017-2027F









Report Title: Global Minimally Invasive Biopsy Techniques Market By Product Offered (Tests, Kits & Consumables, Instruments), By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others {Breath Biopsy etc.}), By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others {miRNA, CTECs, circRNA etc.}), By Application (Clinical v/s Therapeutic), By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions), By Region, Competition Forecast & Opportunities, 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others), By Product (Oral Consumption, External Consumption, Surgical Treatment), By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others), and By Region

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others), By Product (Oral Consumption, External Consumption, Surgical Treatment), By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others), and By Region

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region

Medication Reminder Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Type (Mobile Phone Reminders, In-Home Electronic Devices, Portable Reminder Devices), By End User (Homecare, Hospitals & Clinics, Others), By Company and By Region

Medication Reminder Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (Mobile Phone Reminders, In-Home Electronic Devices, Portable Reminder Devices), By End User (Homecare, Hospitals & Clinics, Others), By Company and By Region

Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, Others), By Company and By Region

Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, Others), By Company and By Region

Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region

Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region